Daniel Nissim has filed an amendment to his Schedule 13G, updating his ownership status in IM Cannabis Corp. This filing, submitted on November 13, 2026, is significant as it provides insights into Nissim's stake in the company and reflects the current state of the medicinal chemicals and botanical products industry.

Background

Daniel Nissim is a notable figure in the investment community, primarily recognized for his involvement with J.B.D Innovation Ltd. This company is linked to IM Cannabis Corp., which operates within the medicinal chemicals and botanical products sector. The recent filing is part of a series of updates, with the previous one submitted on September 30, 2026.

What the Filing Says

The recent Schedule 13G/A filing indicates that Nissim remains the sole owner and director of J.B.D Innovation Ltd., with no significant changes in beneficial ownership reported. The filing states, "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities." This suggests that Nissim's holdings are not intended to influence the control of IM Cannabis Corp.

Impact

This update may affect stakeholders within IM Cannabis Corp. and the broader medicinal chemicals industry. Investors and analysts will likely scrutinize such filings to gauge market sentiment and potential shifts in ownership dynamics. Nissim's position as CEO of J.B.D Innovation Ltd. adds a layer of interest for those monitoring corporate governance within the sector.

What's Next

The filing does not say what happens next.